John Xu

Chief Executive Officer at Jemincare Therapeutics Corp.

Consumer Services

Health Technology

Profile

John Xu is the founder and Chief Executive Officer of Jemincare Therapeutics Corp.
which is founded in 2018.
He was also a Senior Vice President of Strategic Alliances at Abpro Corp.
from 2017 to 2019.
Dr. Xu holds a doctorate from Zhongshan Hospital Fudan University, a graduate degree from Chicago Medical School, and an MBA from the University of Colorado Colorado Springs.

John Xu active positions

Companies	Position	Start
Jemincare Therapeutics Corp. Jemincare Therapeutics Corp. BiotechnologyHealth Technology Jemincare Therapeutics Corp. is a pharmaceutical company. It plans to in license the global and China rights of the large and small molecule clinical stage programs in therapeutic areas such as oncology, cardiovascular and kidney disease. The company was founded by John Xu in November 2018 and is headquartered in Princeton, NJ.	Chief Executive Officer	31/10/2018

All active positions of John Xu

Former positions of John Xu

Companies	Position	End
ABPRO CORPORATION	Corporate Officer/Principal	-

See the detail of John Xu's experience

Training of John Xu

Zhongshan Hospital Fudan University	Doctorate Degree
Chicago Medical School	Graduate Degree
University of Colorado Colorado Springs	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Xu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Abpro Corp. Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA.	Health Technology
Jemincare Therapeutics Corp. Jemincare Therapeutics Corp. BiotechnologyHealth Technology Jemincare Therapeutics Corp. is a pharmaceutical company. It plans to in license the global and China rights of the large and small molecule clinical stage programs in therapeutic areas such as oncology, cardiovascular and kidney disease. The company was founded by John Xu in November 2018 and is headquartered in Princeton, NJ.	Health Technology